Logo (Actavis) 455 (Deferasirox 250 mg)
Pill with imprint Logo (Actavis) 455 is White, Round and has been identified as Deferasirox 250 mg. It is supplied by Actavis Pharma, Inc..
Deferasirox is used in the treatment of thalassemia; iron overload; hemochromatosis; hemosiderosis and belongs to the drug class chelating agents. Risk cannot be ruled out during pregnancy. Deferasirox 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo (Actavis) 455
Deferasirox
- Imprint:
- Logo (Actavis) 455
- Strength:
- 250 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Chelating agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Actavis Pharma, Inc.
- National Drug Code (NDC):
- 45963-0455
More about deferasirox
- Deferasirox Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- Drug class: chelating agents
Consumer resources
- Deferasirox
- Deferasirox Tablets
- Deferasirox Tablets For Oral Suspension
- Deferasirox Sprinkle Granules
- Deferasirox (Advanced Reading)
Other brands: Jadenu, Exjade, Jadenu Sprinkle
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
